Jun. 9 at 7:24 PM
$MBRX We should be in a short countdown to the readout for the 45 patients. Of course, management have been holding this carrot out in front for a while, but it is approaching. Annamycin could be the next generation Anthracycline. Results will show just how good. It does have a lot of boxes checked and for all the possible promise this company sits at what 12-14 m/c? Ok, they have dragged the trials and testing out since acquiring A, oh and that R/S didn't help credibility. Watched Wally explain the potential and pretty convincing. Might as well pick up a ticket and watch the show. Cheers-
